CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Sept. 20, 2006--Dr. Andrew C. von Eschenbach, the acting commissioner of the U.S. Food and Drug Administration, will be the featured speaker at the Southeastern BIO Investor Forum, set for Atlanta in early November. Dr. von Eschenbach, a urological surgeon and a former head of the National Cancer Institute, found himself thrust into controversy last spring as the FDA struggled with the debate over the Plan B contraceptive drug.
